Scleroderma Patients' sleep troubles under the microscope
NCT ID NCT07175246
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will use an overnight sleep test (polysomnography) to measure breathing problems during sleep in 30 adults with systemic sclerosis (scleroderma). The goal is to find out how common sleep-disordered breathing is in this group. No treatment is given—this is purely an observation to gather data.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal how common sleep breathing problems are in scleroderma, pointing toward better screening and care.
- What could go wrong
- This is a small, early observational study (30 people) that only measures sleep patterns—it does not test any treatment. Results may not apply to all scleroderma patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLEEP DISORDERED BREATHING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assiut University hospital
Asyut, Asyut Governorate, 71515, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune clues in the blood may foretell heart trouble
- Could removing tonsils supercharge a sleep apnea implant?
- Blood particles may reveal hidden clues to scleroderma complications
- Could a simple injection dissolve painful calcium lumps in rare diseases?
- Pregnancy sleep problems may harm blood vessels
- Finger injections aim to loosen stiff hands in scleroderma